Previous Article | Next Article ![]()
Infection and Immunity, May 2002, p. 2264-2270, Vol. 70, No. 5
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.5.2264-2270.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Institut für Infektiologie, Zentrum für Molekularbiologie der Entzündung, Westfälische Wilhelms-Universität Münster, D-48149 Münster, Germany
Received 28 August 2001/ Returned for modification 4 December 2001/ Accepted 23 January 2002
|
|
|---|
|
|
|---|
The tib locus (enterotoxigenic invasion locus B), originally identified in enterotoxigenic Escherichia coli (ETEC) strain H10407, confers adherence and invasion properties to E. coli K12 strains (10, 11). The tib locus encodes four proteins TibA to -D. TibA is synthesized as a 100-kDa precursor and seems to be the adhesin/invasin for human intestinal epithelial cells (17). The amino acid sequence of TibA shows homology to that of AIDA-I in the N-terminal part and to that of the ß-barrel structure of AIDAc in the C-terminal part. However, in contrast to what is found for AIDA, only the signal sequence is cleaved in TibA and no additional C-terminal processing was detected. Therefore, TibA remains covalently connected to the surface of the bacteria (16). Interestingly, the functional form of TibA is modified by the addition of carbohydrates very much reminiscent of AIDA-I (16). This modification is mediated by the TibC protein (J. G. Mammarappallil, B. W. Hronek, L. D. Mettenburg, and E. A. Elsinghorst, Abstr. 101st Gen. Meet. Am. Soc. Microbiol., abstr. B57, 2001), which exhibits a high sequence similarity to the AAH protein.
Because of the apparent homology of the two systems, we hypothesized that also in the tib locus the TibC protein represents a heptosyltransferase. Therefore, we were interested to investigate whether this novel putative heptosyltransferase is specific for the tib locus of enterotoxigenic E. coli (ETEC) or whether it might be able to replace the AAH heptosyltransferase of the AIDA system, generating a functional AIDA-I adhesin. Here we report on the functional substitution of the AAH heptosyltransferase and the modification of AIDA-I by several TibC-homologous proteins derived from different ETEC strains.
|
|
|---|
-) (1) and BL21(DE3) (F- ompT hsdSB [rB- mB-] gal dcm T7 gene1) (24) were used. E. coli clinical isolates of different origins were employed (Table 1). T7 expression vector pET-20b(+) (Novagen, Bad Soden, Germany) has a pBR322 origin and mediates ampicillin resistance, and vector pGP1-2 has a P15A origin and mediates kanamycin resistance (29). Plasmids pIB264 (2) and pIB9 (5) are pBR322 derivatives and confer ampicillin resistance. Plasmid pIB264 harbors the genes for the expression of the authentic AIDA system (aah and aidA). In pIB9 (5) the aah gene has been deleted. Bacteria were grown in standard I medium (Merck, Darmstadt, Germany). For maintenance of plasmids the medium was supplemented with the appropriate antibiotic (100 µg of ampicillin/ml and/or 30 µg of kanamycin/ml). |
View this table: [in a new window] |
TABLE 1. E. coli clinical isolates used in this study
|
|
View this table: [in a new window] |
TABLE 2. Sequences of oligonucleotide primers used in this study
|
For the preparation of whole-cell lysates bacteria were suspended in 62.5 mM Tris-HCl (pH 6.8)-20% glycerol-3% sodium dodecyl sulfate (SDS)-8% ß-mercaptoethanol and incubated for 10 min at 100°C.
After protein separation by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting was performed in 25 mM Tris-HCl (pH 7.2) essentially as described previously (6, 30). The nitrocellulose membrane was blocked with 5% skim milk-phosphate-buffered saline (PBS) for 1 h at room temperature. The different antisera were applied in 0.1% bovine serum albumin (BSA)-PBS. After 1 h of incubation the nitrocellulose was washed three times for 10 min each with 0.06% Brij 35-PBS and incubated with a 1:5,000 dilution of alkaline phosphatase (AP)-conjugated second antibody (Jackson ImmunoResearch Laboratories, West Grove, Pa.) in 0.1% BSA-PBS. Following repeated washings with 0.06% Brij 35-PBS, the bound antibody was visualized by incubation with nitroblue tetrazolium-BCIP (5-bromo-4-chloro-3-indolylphosphate as the substrate in AP buffer (100 mM Tris-HCl [pH 9.5], 1 mM MgCl2).
The following antisera were used: (i) antiserum raised against C600(pIB4) exhaustively preadsorbed against C600(pBR322), which recognizes primarily the protein backbone of the AIDA-I adhesin (4); (ii) antiserum raised against the isolated and purified AIDAc protein carrying an additional signal sequence (26); and (iii) antiserum raised against solubilized AIDA-I adhesin recognizing the modification (5).
Adhesion assay. Bacterial adherence to HeLa cells was monitored essentially as described by Cravioto et al. (7) with modifications. For each assay about 108 bacteria grown overnight at 37°C with aeration in standard I medium (Merck) were incubated for 5 min in 1 ml of PBS containing 0.5% D-mannose. The bacterial suspension was added to HeLa cell monolayers on coverslips, just before the monolayers reached confluence. After 1 h of incubation at 37°C, the cells were washed extensively with PBS to remove any nonadherent bacteria. The cells were fixed in 70% methanol, stained with Giemsa (10% solution in water) for better contrast, and evaluated for adhering bacteria by light microscopy.
Detection of a glycan modification.
After separation by SDS-PAGE and Western blotting, glycoproteins were detected by employing the DIG glycan detection kit (Roche Diagnostics). Oxidation of carbohydrate residues was performed in 10 mM sodium metaperiodate in 100 mM sodium acetate buffer (pH 5.5) for 20 min. After being washed with PBS, the filter was incubated with digoxigenin (DIG)-3-O-succinyl-
-aminocaproic acid-hydrazide for 1 h followed by a washing with PBS and incubation with blocking reagent. DIG-labeled proteins were detected with horseradish peroxidase-labeled anti-DIG antibodies. For visualization of bound antibodies the membranes were developed with Super Signal West Pico chemiluminescent substrate (Pierce Chemical Co., Rockford, Ill.) and subsequently exposed to X-ray film.
|
|
|---|
![]() View larger version (53K): [in a new window] |
FIG. 1. Comparative sequence analysis of AAH and TibC. (A) Homology between the amino acid sequences of the AAH and the TibC proteins and the consensus sequence of heptosyltransferases (HEP). Letters between the consensus sequence of heptosyltransferases and the AAH sequence, identical amino acids (uppercase letter, strong consensus positions; lowercase letter, best identity at a weak consensus position); lines between the sequence of the AAH protein and the TibC protein, match lines (exact matches); , mutated cysteine residue leading to a complete loss of activity in the recombinant TibC of ETEC strain TX-1. (B) Comparison of the consensus sequences of the N-terminal repeat regions of AIDA-I and TibA.
|
Further comparative analysis revealed additional homologies between AIDA-I and TibA. This sequence homology is most significant in the N-terminal region, where in both proteins repeats of a distinct amino acid sequence motif have been identified. The consensus sequence derived from these repetitive motifs is given in Fig. 1B. Therefore, not only the modifying but also the modified proteins exhibit a significant sequence homology.
PCR analysis of ETEC strains. To identify the tib locus in further ETEC strains, we examined 12 ETEC strains derived from two different strain collections for the presence of tibC by PCR analysis as described in Materials and Methods. As a control we used AIDA prototype diffuse-adhering E. coli (DAEC) strain 2787 and recombinant strain C600(pIB264), which both express the AIDA system, and E. coli C600. Total DNA was used as the template with primers CM1 and CM2, which were designed to be complementary to the tibC gene of ETEC H10407 in a region where it is highly homologous to the aah gene. Amplification by PCR should result in a DNA fragment of 265 bp. With total DNA from E. coli C600 as the template no DNA fragment of the expected size could be obtained, whereas PCR amplification of total DNA derived from strains C600(pIB264) and DAEC 2787 generated a small amount of the expected fragment. In 4 of the 12 ETEC strains analyzed by PCR a fragment indicative of the presence of the tibC gene could be amplified. This also showed that the tib locus is apparently not a common denominator of ETEC strains, as it was found in only one-third of the strains investigated in this study.
Cloning of the tibC gene from different ETEC strains. Total DNA of the four tibC-positive ETEC strains was used as a template in PCRs with primers CM5 and CM6 (flanking the tibC gene in ETEC H10407) as described in Materials and Methods. The amplified 1.8-kb DNA fragment contained the tibC gene and 600 bp of tibA. Specific amplification was achieved in all four strains. The fragment was restricted with NdeI and EcoRI and ligated with vector pET-20b(+) restricted with the same enzymes. In the resulting plasmids (pCM-I series) the tibC gene is under the control of the T7 promoter. Therefore, to test the function of the cloned genes, it was necessary to reclone the appropriate DNA fragment in pGP1-2. This vector contains a P15A origin and is therefore compatible with the plasmids derived from pBR322 (ColE1 origin), such as pIB9. The pCM-I plasmids were restricted with BglII and EcoRI. The 1.9-kb fragment containing the T7 promoter and the tibC gene was isolated from an agarose gel, ligated with vector pGP1-2 restricted with BamHI and EcoRI, and transformed in E. coli C600. The resulting plasmids were analyzed by restriction analysis and denoted pCM-II.
Expression of the TibC protein. To analyze the recombinant TibC protein, the pCM-II plasmids were transformed into E. coli strain BL21(DE3). Total cellular proteins were separated by SDS-PAGE and stained with Coomassie blue. In all samples an additional protein band was detected after induction with IPTG (Fig. 2). It corresponds to a protein with a molecular mass of about 45 kDa, as expected for the TibC protein. Bacteria grown in the absence of IPTG showed small amounts of the protein, whereas in bacteria grown in the presence of IPTG a larger amount of the protein could be detected. The amount of expressed TibC protein varies among the four recombinant strains.
![]() View larger version (87K): [in a new window] |
FIG. 2. Expression of recombinant TibC protein in E. coli BL21(DE3). Total cellular proteins of different recombinant E. coli strains were separated by SDS-10% PAGE. The plasmids contain a tibC gene derived from the particular ETEC strain indicated in the plasmid name. Proteins were detected by staining with Coomassie blue. The total cellular extracts were prepared from recombinant bacteria without (-) and with (+) prior induction of T7 polymerase synthesis with IPTG for 3 h. Molecular sizes of the marker proteins are given in kilodaltons.
|
![]() View larger version (66K): [in a new window] |
FIG. 3. Western blots and glycan detection of total cellular proteins extracted from different E. coli strains. Proteins were separated by SDS-10% PAGE. AIDA-specific proteins were identified with preadsorbed antiserum raised against C600(pIB4) (A), anti-AIDA-I serum (B), and anti-AIDAc serum (C). (D) Glycoproteins were labeled with DIG-hydrazide after periodate oxidation and visualized with an anti-DIG antibody. Molecular sizes of the marker proteins are given in kilodaltons. Open arrow, proprotein; solid arrow, AIDA-I; open arrowhead, unmodified AIDA-I; solid arrowhead, AIDAc
|
![]() View larger version (144K): [in a new window] |
FIG. 4. Adherence properties of E. coli strains expressing a recombinant tibC gene. (A) BL21(DE3)(pIB9, pCM117-II); (B) BL21(DE3)(pIB9, pCM147-II); (C) BL21(DE3)(pIB9, pCMTX-II); (D) BL21(DE3)(pIB9, pCM469-II). HeLa cell monolayers were incubated with 108 bacteria in PBS (37°C) in the presence of 0.5% D-mannose. After extensive washing with PBS, cells and bacteria were stained with Giemsa for better contrast and assayed for adherence by light microscopy. Bar, 25 µm.
|
|
View this table: [in a new window] |
TABLE 3. Comparison of the amino acid sequences of the recombinant TibC proteins and associated nucleotide sequencesa
|
Examination of the tibC-harboring ETEC strains. Western blot analysis of total cellular proteins of ETEC strains with anti-AIDA serum recognized protein bands corresponding in size to the modified TibA protein in all four strains (Fig. 5). As the anti-AIDA serum recognizes the modification of the AIDA adhesin, this result indicates that in all four ETEC strains including TX-1 TibC exhibits glycosyltransferase activity and TibA is modified. Furthermore, recognition of the modification in TibA by antibodies directed against the modification of AIDA-I suggests that the modifications by carbohydrate moieties of AIDA-I and TibA are very similar if not identical.
![]() View larger version (42K): [in a new window] |
FIG. 5. Western blot of total cellular proteins extracted from different E. coli strains. ETEC strains 117/86, 147/1, TX-1, and 469ST harbor the tib locus, whereas ETEC isolate G1253 does not. DAEC 2787 expressing the AIDA system serves as a positive control. Proteins were separated by SDS-10% PAGE. Modified proteins were identified with anti-AIDA-I serum recognizing the heptosyl modification. Solid arrowheads, AIDA proprotein and modified AIDA-I adhesin; open arrowhead, modified TibA protein. Molecular sizes of the marker proteins are given in kilodaltons.
|
|
|
|---|
Plasmid-encoded autotransporter adhesin AIDA was identified in a clinical isolate of E. coli and was subsequently characterized in our laboratory (2-5, 12, 26). Recently, we demonstrated that the AIDA-I adhesin is posttranslationally modified with, on average, 19 heptose residues, and we further showed that this modification is essential for the adhesive function of the protein (5). We identified the modifying enzyme as the product of the aah gene, which has been found to be always associated with a functional AIDA system (5, 21). The AAH protein (autotransporter adhesin heptosyltransferase) is a cytoplasmic heptosyltransferase which utilizes activated ADP-glycero-manno-heptose residues pinched from the pathway of LPS synthesis to specifically modify the AIDA protein.
TibA, a chromosomally encoded glycosylated autotransporter adhesin/invasin, was described by Elsinghorst and collegues (11, 16, 17). Recently, it was reported (Mammarappallil et al., Abstr. 101st Gen. Meet. Am. Soc. Microbiol.) that the glycosylation of TibA is apparently mediated by the product of the tibC gene. Sequence comparison of the tibC gene and the aah gene, which had been shown to encode a heptosyltransferase (5), demonstrated significant similarity. In addition, homology to the consensus sequence for the known heptosyltransferases involved in LPS core synthesis could be identified in the products of both genes (5, 16). AIDA-I and TibA seem to be functionally and structurally related proteins, as both have repetitive sequence motifs in their N termini (5, 16). Therefore, we hypothesized that TibC also might represent a heptosyltransferase, and we were interested to see whether TibC might be able to substitute for AAH in the AIDA system and as such restore the adhesin activity of the AIDA-I autotransporter adhesin.
For the identification of the tibC gene by PCR we investigated 12 ETEC isolates derived from two different strain collections. Four strains harboring the tibC gene were identified; the genes were amplified by PCR and subsequently cloned and expressed under the control of a T7 promoter (Fig. 2). This indicates that the tibC gene might be present in only a fraction of ETEC strains (11) and is not a conserved gene. Reconstitution of a recombinant strain which expresses only the AIDA autotransporter and which lacks the aah heptosyltransferase gene with three of the four cloned tibC genes derived from different ETEC strains restored glycosylation and the activity of the AIDA-I adhesin. Glycosylation was demonstrated by the shift in electrophoretic mobility and reactivity in the glycan detection assay (Fig. 3). Furthermore, three out of four recombinant TibC proteins also restored the diffuse-adherence phenotype mediated by the AIDA-I adhesin (Fig. 4). However, the recombinant tibC gene derived from ETEC strain TX-1 did not restore the activity of AIDA-I, although the protein was expressed in sufficient amounts (Fig. 2). Further analysis of the recombinant DNA sequences detected a near identity to the published tibC sequence of ETEC strain H10407, leading to only a few dispersed single-amino-acid exchanges. In the recombinant tibC gene of strain TX-1, however, we identified a nucleotide exchange at position 1072 that resulted in amino acid exchange Cys358Arg. As in the four known TibC sequences a cysteine residue is conserved at this position, and it appeared that this single mutation might be responsible for the lack of activity. To prove that this is really the case, we reintroduced a cysteine at this position (Arg358Cys; pCMTX-III) by site-specific mutagenesis. The introduction of the conserved cysteine residue fully restored the activity of TibC. This indicates either that the cysteine residue is directly involved in the catalytic activity of the glycosyltransferase or, more likely, that this cysteine is part of an essential disulfide loop needed for the correct folding of the enzyme. Interestingly, this cysteine residue is the only Cys of the 10 to 12 cysteines shared by AAH and TibC which is also present in the heptosyltransferase consensus sequence (Fig. 1A). Other single-amino-acid exchanges, compared to the prototype H10407 TibC sequence, identified in two further recombinant TibC proteins apparently did not influence their activity (Table 3).
Interestingly, in the wild-type ETEC strains including TX-1, a glycosylated protein corresponding to the modified TibA protein (104 kDa) could be identified (Fig. 5) by the modification-specific anti-AIDA antiserum (5). This clearly demonstrated that in the wild-type ETEC TX-1 strain TibC is active and, furthermore, suggested that the inactivating mutation might have been introduced by the Taq polymerase during PCR amplification. Reamplification and sequencing of tibC derived from ETEC strain TX-1 resulted in an active TibC protein carrying the expected cysteine residue at position 358.
Recognition of TibA in all four tib-positive ETEC strains by the anti-AIDA-I antiserum (Fig. 5) demonstrated that the glycosylation of TibA is related if not identical to the modification with heptose residues recently identified in AIDA-I (5). In conclusion, our results strongly indicate that, like the AAH protein, the TibC protein functions as a protein-specific heptosyltransferase. With respect to the homology of the repetitive sequences of the N terminus of AIDA-I and TibA (Fig. 1), it is tempting to speculate that one of the serine residues (boldface) of consensus sequence TV-NSGG-Q-V-SGG-A--, derived from the AIDA-I repetitive motif, might represent the actual modification site. However, this has to be confirmed by further studies.
In summary, we show that the TibC glycosyltransferase, identified as the product of the chromosomal tib loci of certain ETEC strains, is able to functionally replace the autotransporter adhesin heptosyltransferase (AAH) of the plasmid-encoded AIDA system in fully restoring activity to the AIDA-I adhesin depending on the modification of AIDA with heptose residues. Therefore, the AAH and the TibC proteins represent the first examples of a novel class of heptosyltransferases which target proteins.
This study was supported in part by the Deutsche Forschungsgemeinschaft (DFG SCHM 770/7-2; SFB293 B5).
C. Moormann and I. Benz contributed equally to this work.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»